96 related articles for article (PubMed ID: 19356121)
1. First Mariner Mos1 transposase inhibitors.
Bouchet N; Bischerour J; Germon S; Guillard J; Dubernet M; Viaud-Massuard MC; Delelis O; Ryabinin V; Bigot Y; Augé-Gouillou C
Mini Rev Med Chem; 2009 Apr; 9(4):431-9. PubMed ID: 19356121
[TBL] [Abstract][Full Text] [Related]
2. A Mos1 transposase in vivo assay to screen new HIV-1 integrase inhibitors.
Cancian M; Loreto ELS
Genetica; 2018 Apr; 146(2):243-247. PubMed ID: 29352755
[TBL] [Abstract][Full Text] [Related]
3. Dissecting Tn5 transposition using HIV-1 integrase diketoacid inhibitors.
Czyz A; Stillmock KA; Hazuda DJ; Reznikoff WS
Biochemistry; 2007 Sep; 46(38):10776-89. PubMed ID: 17725323
[TBL] [Abstract][Full Text] [Related]
4. Natural stilbenoids isolated from grapevine exhibiting inhibitory effects against HIV-1 integrase and eukaryote MOS1 transposase in vitro activities.
Pflieger A; Waffo Teguo P; Papastamoulis Y; Chaignepain S; Subra F; Munir S; Delelis O; Lesbats P; Calmels C; Andreola ML; Merillon JM; Auge-Gouillou C; Parissi V
PLoS One; 2013; 8(11):e81184. PubMed ID: 24312275
[TBL] [Abstract][Full Text] [Related]
5. Structural basis of Mos1 transposase inhibition by the anti-retroviral drug Raltegravir.
Wolkowicz UM; Morris ER; Robson M; Trubitsyna M; Richardson JM
ACS Chem Biol; 2014 Mar; 9(3):743-51. PubMed ID: 24397848
[TBL] [Abstract][Full Text] [Related]
6. Tn5 transposase as a useful platform to simulate HIV-1 integrase inhibitor binding mode.
Barreca ML; Ortuso F; Iraci N; De Luca L; Alcaro S; Chimirri A
Biochem Biophys Res Commun; 2007 Nov; 363(3):554-60. PubMed ID: 17889829
[TBL] [Abstract][Full Text] [Related]
7. Binding mode prediction of strand transfer HIV-1 integrase inhibitors using Tn5 transposase as a plausible surrogate model for HIV-1 integrase.
Barreca ML; De Luca L; Iraci N; Chimirri A
J Med Chem; 2006 Jun; 49(13):3994-7. PubMed ID: 16789757
[TBL] [Abstract][Full Text] [Related]
8. DNA-binding activity and subunit interaction of the mariner transposase.
Zhang L; Dawson A; Finnegan DJ
Nucleic Acids Res; 2001 Sep; 29(17):3566-75. PubMed ID: 11522826
[TBL] [Abstract][Full Text] [Related]
9. Transposase-transposase interactions in MOS1 complexes: a biochemical approach.
Carpentier G; Jaillet J; Pflieger A; Adet J; Renault S; Augé-Gouillou C
J Mol Biol; 2011 Jan; 405(4):892-908. PubMed ID: 21110982
[TBL] [Abstract][Full Text] [Related]
10. The mariner Mos1 transposase produced in tobacco is active in vitro.
Thomas X; Hedhili S; Beuf L; Demattéi MV; Laparra H; Khong GN; Breitler JC; Montandon F; Carnus E; Norre F; Burtin D; Gantet P; Bigot Y; Renault S
Genetica; 2010 May; 138(5):519-30. PubMed ID: 19847655
[TBL] [Abstract][Full Text] [Related]
11. Mutant Mos1 mariner transposons are hyperactive in Aedes aegypti.
Pledger DW; Coates CJ
Insect Biochem Mol Biol; 2005 Oct; 35(10):1199-207. PubMed ID: 16102425
[TBL] [Abstract][Full Text] [Related]
12. Mariner Mos1 transposase dimerizes prior to ITR binding.
Augé-Gouillou C; Brillet B; Germon S; Hamelin MH; Bigot Y
J Mol Biol; 2005 Aug; 351(1):117-30. PubMed ID: 15992822
[TBL] [Abstract][Full Text] [Related]
13. Targeting Tn5 transposase identifies human immunodeficiency virus type 1 inhibitors.
Ason B; Knauss DJ; Balke AM; Merkel G; Skalka AM; Reznikoff WS
Antimicrob Agents Chemother; 2005 May; 49(5):2035-43. PubMed ID: 15855529
[TBL] [Abstract][Full Text] [Related]
14. Kinetic analysis of the interaction of Mos1 transposase with its inverted terminal repeats reveals new insight into the protein-DNA complex assembly.
Esnault C; Jaillet J; Delorme N; Bouchet N; Renault S; Douziech-Eyrolles L; Pilard JF; Augé-Gouillou C
Chembiochem; 2015 Jan; 16(1):140-8. PubMed ID: 25487538
[TBL] [Abstract][Full Text] [Related]
15. cAMP protein kinase phosphorylates the Mos1 transposase and regulates its activity: evidences from mass spectrometry and biochemical analyses.
Bouchet N; Jaillet J; Gabant G; Brillet B; Briseño-Roa L; Cadene M; Augé-Gouillou C
Nucleic Acids Res; 2014 Jan; 42(2):1117-28. PubMed ID: 24081583
[TBL] [Abstract][Full Text] [Related]
16. Mariner Mos1 transposase optimization by rational mutagenesis.
Germon S; Bouchet N; Casteret S; Carpentier G; Adet J; Bigot Y; Augé-Gouillou C
Genetica; 2009 Dec; 137(3):265-76. PubMed ID: 19533383
[TBL] [Abstract][Full Text] [Related]
17. Biochemical characterization and comparison of two closely related active mariner transposases.
Trubitsyna M; Morris ER; Finnegan DJ; Richardson JM
Biochemistry; 2014 Feb; 53(4):682-9. PubMed ID: 24404958
[TBL] [Abstract][Full Text] [Related]
18. A mechanism for Tn5 inhibition. carboxyl-terminal dimerization.
Mahnke Braam LA; Goryshin IY; Reznikoff WS
J Biol Chem; 1999 Jan; 274(1):86-92. PubMed ID: 9867814
[TBL] [Abstract][Full Text] [Related]
19. Subunit interactions in the mariner transposase.
Lohe AR; Sullivan DT; Hartl DL
Genetics; 1996 Nov; 144(3):1087-95. PubMed ID: 8913752
[TBL] [Abstract][Full Text] [Related]
20. Analyses of cis -acting elements that affect the transposition of Mos1 mariner transposons in vivo.
Pledger DW; Fu YQ; Coates CJ
Mol Genet Genomics; 2004 Aug; 272(1):67-75. PubMed ID: 15221453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
